James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.

Mary Aronow is an Ophthalmologist in Mount Airy, Maryland. Dr. Aronow is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. Her top areas of expertise are Melanoma of the Eye, Choroid Plexus Carcinoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy. Dr. Aronow is currently accepting new patients.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as a Distinguished provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Pancreaticoduodenectomy.

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic. Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center. Make A Gift. Dr. Quon is rated as a Distinguished provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Dry Mouth, Gastrostomy, and Prostatectomy.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Advanced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Pancreatic Cancer.

Marianne Cowley, M.D., is a clinical associate of ophthalmology and retina specialist at the Wilmer Eye Institute's Green Spring Station and Odenton, Maryland locations. Dr. Cowley specializes in the diagnosis and treatment of conditions such as age-related macular degeneration (dry and wet) and diabetic retinopathy. Dr. Cowley comes from private practice where she has focused on clinical excellence and patient experience in retinal care. For many years, Dr. Cowley volunteered her services with the University of Louisville and has made trips internationally to assist in providing retinal care. Dr. Cowley is rated as an Advanced provider by MediFind in the treatment of Melanoma of the Eye. Her top areas of expertise are Melanoma of the Eye, Choroid Plexus Carcinoma, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Fernando Arevalo is an Ophthalmologist in Baltimore, Maryland. Dr. Arevalo is rated as an Advanced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.

Dr. Ana Kiess's clinical focus is on the treatment of prostate cancer and head and neck cancers with external beam radiotherapy and radiopharmaceutical therapies. Her research concentrates on the integration of new radiopharmaceutical therapies and dosimetry techniques into the clinic. Dr. Kiess received her bachelors of science degree in chemical engineering from the University of Virginia, after which she obtained a doctorate of medicine and a doctorate of philosophy degree in biomedical engineering from Duke University. Following medical school, she matriculated to the resident staff at Memorial Sloan Kettering Cancer Center, receiving extensive oncologic training and research experience. She also completed a postdoctoral research fellowship at Johns Hopkins University in the Department of Radiology. Make A Gift. Dr. Kiess is rated as an Advanced provider by MediFind in the treatment of Melanoma of the Eye. Her top areas of expertise are Prostate Cancer, Laryngeal Cancer, Throat Cancer, Gastrostomy, and Adenoidectomy.

Akrit Sodhi, M.D, Ph.D., is an Associate Professor of Ophthalmology at the Wilmer Eye Institute and holds the Branna and Irving Sisenwein Professorship in Ophthalmology. Dr. Sodhi specializes in the medical and surgical management of complex vitreoretinal diseases. Dr. Sodhi was trained at the University of California at Los Angeles (UCLA), the University of California at Davis, and the National Institutes of Health. After obtaining his M.D. and Ph.D., he interned at Sinai Hospital in Baltimore and completed his Ophthalmology Residency training at the Wilmer Eye Institute at Johns Hopkins in 2008. He then pursued a fellowship in vitreoretinal surgery at Wilmer where he also served as the Assistant Chief of Service (Chief Resident). Dr. Sodhi joined the faculty of the Retina Division at Wilmer in 2010. His research interests, currently sponsored by grants from the National Eye Institute, include the examination of the role of hypoxia inducible factor (HIF) and HIF-regulated genes in ocular diseases, including diabetic eye disease, age-related macular degeneration, sickle cell retinopathy, retinal vein occlusions, and uveal melanoma. Dr. Sodhi's lab has identified novel therapeutic targets for the treatment of these vision-threatening diseases. Dr. Sodhi is rated as an Advanced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Late-Onset Retinal Degeneration.

Elizabeth Bower is a primary care provider, practicing in Internal Medicine in Ellicott City, Maryland. Dr. Bower is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. Her top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol.

Fatemeh Rajaii, M.D., Ph.D., is an associate professor of ophthalmology at the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Rajaii specializes in reconstructive and cosmetic eyelid, orbital and facial surgery. This includes the surgical treatment of eyelid malpositions, facial skin cancers, tear drainage issues, orbital tumors and Thyroid Eye Disease. She treats children and adults. Dr. Rajaii's research interests include the effects of eyelid surgery on ocular surface disease and visual function, oculoplastic surgical techniques and mechanisms underlying orbital disease. Dr. Rajaii received her M.D. and Ph.D. (neuroscience) degrees from Johns Hopkins University School of Medicine. She completed an internship in internal medicine at Mercy Medical Center prior to completing her ophthalmology residency at the Wilmer Eye Institute. She completed a fellowship in ophthalmic plastic, orbital and facial cosmetic surgery at the University of Michigan prior to joining the Wilmer faculty. Dr. Rajaii is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. Her top areas of expertise are Orbital Cellulitis, Eyelid Drooping, Ptosis, and Periorbital Cellulitis.

"Dr. Batouli received his Bachelor’s (Echols Scholar- Interdisciplinary Studies) and Master’s (Epidemiology) degrees from the University of Virginia. Subsequent to Medical School at Mount Sinai School of Medicine, he completed his internship at Northwestern University School of Medicine. He completed his radiology residency at Montefiore Medical Center/Albert Einstein College of Medicine where he was selected Chief Resident. Dr. Batouli completed his Cross-sectional Imaging Fellowship at the Johns Hopkins University School of Medicine where he was chosen as ""Outstanding Fellow of the Year"" by the radiology residents for his excellence as a radiologist and educator. He returns to Johns Hopkins from Mid Atlantic Permanente Medical Group where he was subspecialty chief of Abdominal Imaging. Previously, he was a partner in a private practice, where he served as group treasurer and Chair of Radiology at a community hospital.". Dr. Batouli is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Pleural Effusion, Pleurisy, Gallbladder Disease, and Diverticular Disease.

Dr. Kronthal joins the Johns Hopkins Community Radiology division from Drs. Groover, Christie and Merritt (GCM), where he has practiced at both Sibley and Suburban Hospitals for more than eleven years. He received his Bachelor of Arts at Haverford College in 1983 and medical degree at the University of Virginia in 1987. Dr. Kronthal performed both his radiology residency and Body Imaging fellowship at Johns Hopkins Hospital from 1998 through 1993. Following his fellowship, he spent twelve years with WBA Imaging, during which time he served as Chairman of the Department of Imaging at Prince George’s Hospital Center. Dr. Kronthal was with GCM from 2005 – 2017 and is the incoming Chairman of Radiology at Sibley Hospital. He is a past president of the District of Columbia Metropolitan Radiological Society. He was awarded fellowship in the American College of Radiology in 2005. Dr. Kronthal is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Muscle Invasive Bladder Cancer, Pleurisy, Pleural Effusion, and ALK-Positive Non-Small Cell Lung Cancer.

Dr. Stefan Loy Zimmerman is a Professor in the Johns Hopkins University School of Medicine in the Departments of Radiology and Medicine (Cardiology). He specializes in cardiothoracic imaging and is the Division Director of Diagnostic Imaging and Director of Cardiac Imaging. He is the program director for the Cardiothoracic Imaging Fellowship in Radiology. Dr. Zimmerman earned his medical degree from the University of Pennsylvania School of Medicine. He completed both a radiology residency and a cardiovascular imaging fellowship at the Hospital of the University of Pennsylvania. His research focuses on the use of CT and MR imaging in the diagnosis and management of cardiovascular diseases. He has particular interest in the use of cardiac imaging for management of arrhythmias, diagnosis and prognosis of arrhythmogenic right and left ventricular cardiomyopathy, and pulmonary hypertension. Dr. Zimmerman is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Alveolar Soft Part Sarcoma, Liposarcoma, Cardiac Ablation, and Transcatheter Aortic Valve Replacement (TAVR).

William Houck is an Oncologist in Baltimore, Maryland. Dr. Houck is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).

Nicholas R. Mahoney, M.D., is an Oculoplastic surgeon at the Wilmer Eye Institute's locations in Bethesda and Baltimore, Maryland. He is the chief of Wilmer's Oculoplastics Division. Dr. Mahoney specializes in surgery of the tissue surrounding the eyes, including the eyelids, eye socket (orbit) and tear drainage system. This includes removal of benign and malignant lesions of the eyelid and eye socket, repair of eyelid and eye socket trauma, reconstruction of the tear ducts and surgery for correcting abnormal eyelid position. Eyelid surgeries include surgeries for drooping eyelids, extra eyelid skin and heavy eyebrows for both functionally reconstructive and cosmetic reasons. Dr. Mahoney received his M.D. from the University of Pennsylvania and completed his ophthalmology residency at the Scheie Eye Institute, Hospital of the University of Pennsylvania and the Children’s Hospital of Philadelphia. He then completed additional specialty training as an American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) fellow at the Wilmer Eye Institute and Johns Hopkins Hospital. Dr. Mahoney joined the Wilmer faculty in 2012. He has held various administrative responsibilities and is currently the Vice Chair of Information Technology & Data Science for the Department of Ophthalmology. Dr. Mahoney is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Ptosis, Eyelid Drooping, Entropion, Blocked Tear Duct, and Osteotomy.

Dr. Cheng Ting Lin is an associate professor of radiology and radiological science at the Johns Hopkins University School of Medicine. His expertise is in diagnostic radiology with particular focus on chest and cardiac imaging. Dr. Cheng Ting Lin received his undergraduate degree from Boston University. He graduated from State University of New York at Stony Brook, where he also completed a radiology residency training program. Dr. Lin completed fellowship training in cardiothoracic imaging at University of Maryland Medical Center. His research interest includes lung cancer screening and diagnosis, chronic obstructive pulmonary disease, Interstitial lung disease, pulmonary embolism, and coronary artery disease. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Lung Nodules, Interstitial Lung Disease, Pulmonary Arteriovenous Fistula, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain.

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Mona Kaleem, M.D. is an Associate Professor of Ophthalmology at the Wilmer Eye Institute. She is a fellowship trained glaucoma and cataract surgeon in Bethesda, Maryland. She is broadly trained in the medical and surgical care of glaucoma. Her excellence in patient care, teaching, and research activities resulted in her selection to the American Glaucoma Society. She was also selected by her peers as a Baltimore Magazine “Top Doctor” in 2018, 2019 and 2021. In 2020, Dr. Kaleem was honored with the American Academy of Ophthalmology's Achievement Award. Dr. Kaleem was born and raised in Maryland. She earned her Bachelor’s degree in Economics with double minors in Biology and Chemistry at Smith College prior to entering the Howard University College of Medicine. There, she was a Trustee Scholar and awardee of the Malcolm X Scholarship due to her leadership in community service. She completed her medical training at Mercy Medical Center, Howard University Hospital, and the Cleveland Clinic. She has a strong interest in volunteerism and has participated in medical missions globally and in underserved areas within the United States. Dr. Kaleem is also known for her involvement in grass roots legislative efforts that impact the way that ophthalmology care is delivered and received in the United States. She is one of the hosts of the Diagnosis Glaucoma podcast and co-authored the book Glaucoma: What Every Patient Should Know with Dr. Harry Quigley. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Kaleem-cv.pdf. Dr. Kaleem is rated as an Experienced provider by MediFind in the treatment of Melanoma of the Eye. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Vitrectomy, and Trabeculectomy.